DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password


EPG Search
Frequent Searches:
Search
Languages

MiMedia - Featured Content

Want to submit or suggest content for the MiMedia Clinical Library?
Contact us here

EPG Online is not responsible for external content

Hemangioblastoma Surgery Video
Featured Content
Browse Other Languages
Parkinson's Disease - understanding, management, diagnosis and treatment information. Medical conferences for the Healthcare professional Cholesterol - understanding, management, diagnosis and treatment information Opioid and Pain Management - understanding, management, diagnosis and treatment information
EPG Online Guidelines Archive
Guidelines 1 - 20 of 159. Previous | Next
Ascending - Descending
Use the links below to sort by different criteria.
Title - Source - Date

AACE MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR MANAGEMENT OF MENOPAUSE - AACE - 1999

The American Association of Clinical Endocrinologists (AACE) believes that menopause is a state of hormone deficiency that should be treated. Our mission is to ensure that women receive appropriate guidance and medical management during their menopausal years. The purpose of these guidelines is to provide a reference source for the evaluation and treatment of the menopausal state. View Guideline (PDF )

Abatacept for the treatment of rheumatoid arthritis - NICE - 2008

Abatacept is not recommended for people with moderate to severe active rheumatoid arthritis who have already tried drugs known as disease-modifying anti-rheumatic drugs (including a 'TNF inhibitor'drug), which didn't work or weren't suitable. Healthcare professionals should not stop prescribing abatacept for people who were already taking it when the guidance was issued. These patients should be able to carry on taking abatacept until they and their specialist decide that it is the right time to stop treatment. View Guideline (PDF )

Acutely ill patients in hospital - NICE - 2007

Sometimes, the health of a patient in hospital may get worse suddenly (this is called becoming acutely ill). There are certain times when this is more likely, for example following an emergency admission to hospital, after surgery and after leaving critical care. However, it can happen at any stage of an illness. It increases the patient's risk of needing to stay longer in hospital, not recovering fully or dying. Monitoring patients (checking them and their health) regularly while they are in hospital and taking action if they show signs of becoming worse can help avoid serious problems. The NICE clinical guideline describes how patients in acute hospitals should be monitored to help identify those whose health becomes worse and how they should be cared for if this happens. The advice in the guideline covers: * all adult patients in hospital, including patients in the emergency department being admitted to hospital and those being moved between departments. It does not specifically look at the care of: * children * patients in critical care areas, for example in an intensive care or high dependency unit * people who are having treatment for symptoms and pain in the final stages of a terminal illness. View Guideline (PDF )

Adalimumab for the treatment of psoriasis - NICE - 2008

Adalimumab (Humira, Abbott Laboratories) is a recombinant human monoclonal antibody that binds specifically to tumour necrosis factor alpha (TNF-α), blocking interaction with its cell-surface receptors and thereby limiting the promotion of inflammatory pathways. View Guideline (PDF )

ADHD Clinical Practice Guidelines - American Academy of Pediatrics - 2005

The guidelines represent the work of a select group of individuals chosen by the Committee on Quality Improvement of the American Academy of Pediatrics and consisting of representatives from the fields of neurology, psychology, child psychiatry, development, education, family practice and epidemiology, and included both academic and practicing pediatricians. View Guideline (Web )

Advice on the safe introduction and continued use of isotretinoin in acne - British Association of Dermatologists - 2003

Since its introduction into clinical trials in the mid 1970's and its widespread use since the early 1980's, isotretinoin has proved a very effective therapy for severe and persistent acne. Initially only used for severe cystic acne, its use has been gradually extended for those with significant but milder disease that has been persistent despite the use of conventional topical and oral therapies. View Guideline (Web )

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update - American heart association - 2006

Since the 2001 update of the American Heart Association (AHA)/American College of Cardiology (ACC) consensus statement on secondary prevention,1 important evidence from clinical trials has emerged that further supports and broadens the merits of aggressive risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. View Guideline (Web )

Anaemia management in chronic kidney disease - NICE - 2006

The NICE clinical guideline on treating anaemia in people with chronic kidney disease covers: * detecting and diagnosing anaemia of chronic kidney disease managing anaemia of chronic kidney disease, and other health problems or treatments that may affect it. It does not specifically look at: * anaemia in people with chronic kidney disease, where the anaemia may be caused by other problems. View Guideline (PDF )

Antenatal and postnatal mental health - NICE - 2007

The advice in the NICE clinical guideline on mental health problems during pregnancy and after giving birth covers: * recognising mental health problems during pregnancy and in the first year after giving birth * the care and treatment (including drugs and psychological treatments) of women who develop a mental health problem during pregnancy or in the first year after giving birth, and women who have a higher chance of developing a problem at this time * the care and treatment (including drugs and psychological treatments) of women who already had a mental health problem before becoming pregnant * how families and carers may be able to support women with mental health problems and get support for themselves. It does not specifically look at: * the care of women with ‘baby blues’ in the first few days after giving birth (this is covered in the NICE guideline on postnatal care) * the treatment of physical health problems during pregnancy and in the first year after giving birth * the treatment of mental health problems at any time other than when planning a pregnancy, during pregnancy and in the first year after giving birth. View Guideline (PDF )

Antenatal care - NICE - 2008

The advice in the NICE guideline covers: * the routine care that all healthy women can expect to receive during their pregnancy. It does not specifically look at: * women who are pregnant with more than one baby, women with certain medical conditions or women who develop a health problem during their pregnancy. View Guideline (PDF )

Anxiety - NICE - 2004

The NICE anxiety clinical guideline covers the care of adults who have panic disorder (with or without agoraphobia) or generalised anxiety disorder. The recommendations address: * diagnosis * medication * psychological treatments * self-care The guideline does not cover the care of people with other anxiety disorders such as post-traumatic stress disorder or obsessive compulsive disorder, which will be addressed in separate guidelines. The guideline does not cover the care of people who have both anxiety and depression. NICE has also issued a guideline on depression. Amendment of recommendations concerning venlafaxine: April 2007 On 31 May 2006 the MHRA issued revised prescribing advice for venlafaxine. This amendment brings the guideline into line with the new advice but does not cover other areas where new evidence may be available. NICE expects to make a decision on a full update later in 2007. View Guideline (Word )

Atopic eczema in children - NICE - 2007

Atopic eczema (often called atopic dermatitis) is one of a group of related, inherited conditions that also includes asthma and hay fever. It can make the skin dry, itchy, red, broken and sore. It sometimes makes the skin darker or lighter for a while. People of all ages can get atopic eczema, but it usually starts in early childhood. It usually improves with age, but some people will have the condition into adulthood. This guideline covers the management of atopic eczema in children from birth up to the age of 12 years, and provides guidance on diagnosis and assessment, management, and providing information and education for children and their parents and carers. View Guideline (PDF )

Atrial fibrillation - NICE - 2006

The NICE clinical guideline on atrial fibrillation covers: the tests that should be used to diagnose atrial fibrillation (AF) the treatment people can expect to be offered depending on the type of AF -they have, including AF that: * comes on suddenly (acute-onset AF) * lasts longer than a week or doesn’t stop without treatment (persistent AF) * is more longstanding (permanent AF) * comes and goes (paroxysmal AF) the treatment people can expect if they have AF then have a stroke. It doesn’t specifically look at the treatment of AF for people who are under 18 years of age, or whose AF is caused by heart disease that they were born with. View Guideline (PDF )

Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults - NICE - 2008

This guideline makes recommendations for the diagnosis and management of attention deficit hyperactivity disorder (ADHD) in children, young people and adults. The guideline does not cover the management of ADHD in children younger than 3 years. The term ‘children’ refers to those aged 11 years and younger; ‘young people’ refers to those between 12 and 18 years. However, these categories are flexible and clinicians should use their judgement about a child or young person’s developmental, as opposed to their chronological, age. View Guideline (PDF )

BHIVA treatment guidelines for TB/HIV infection - BHIVA - 2005

These guidelines have been drawn up to help physicians manage adults with HIV/TB co-infection. We recommend that co-infected patients are managed by a multi-disciplinary team which includes physicians who have expertise in the treatment of both tuberculosis and HIV View Guideline (PDF )

Bipolar disorder - NICE - 2006

The NICE clinical guideline on bipolar disorder covers: * what treatment people with bipolar disorder can expect to be offered, including medication and psychological therapies * advice on self-help * the services that may help people with bipolar disorder, including psychiatric or specialist mental health services * how families and carers may be able to support people with bipolar disorder, and get support for themselves. This guidance has replaced TA66 Bipolar disorder - new drugs View Guideline (PDF )

Blood glucose monitoring CLINICAL GUIDELINE - UCL: Institue of child health - 2002

When performing blood glucose monitoring, staff should be trained in both the theoretical & practical aspects, including the use of the glucose measuring device & instruction on calibration of quality control. View Guideline (Web )

Blood Pressure Monitoring CLINICAL GUIDELINE - UCL - 2004

This guideline offers a definition of what is a blood pressure as well as describing its various phases. It also highlights the difficulties as well as methods and types of equipment used in measuring blood pressure in children. The appendix demonstrates tables of blood pressure measurements for boys and girls aged between 1 and 17 years in relation to 90th and 95th percentiles. View Guideline (Web )

British Guideline on the Management of Asthma - British Thoracic Society - 2008

In 1999 the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) agreed to jointly produce a comprehensive new asthma guideline, both having previously published guidance on asthma. The original BTS guideline dated back to 1990 and the SIGN guidelines to 1996. Both organisations recognised the need to develop the new guideline using explicitly evidence based methodology. The joint process was further strengthened by collaboration with Asthma UK, the Royal College of Physicians of London, the Royal College of Paediatrics and Child Health, the General Practice Airways Group, and the British Association of Accident and Emergency Medicine (now the College of Emergency Medicine). The outcome of these efforts was the British Guideline on the Management of Asthma published in 2003.1 View Guideline (PDF )

British HIV Association and Children’s HIV Association guidelines for the management of HIV infection in pregnant women 2008 - British HIV Association - 2008

The success of antenatal testing for HIV means that more clinicians than ever are involved in the care of women with HIV who are pregnant. Despite very few recent randomized controlled trials regarding the use of antiretroviral therapy (ART) in pregnancy or obstetric interventions, practice is changing. View Guideline (PDF )

Hypertension - understanding, management, diagnosis and treatment information Lysosomal Storage Diseases - understanding, management, diagnosis and treatment information Renal Anaemia - understanding, management, diagnosis and treatment information. Non-small Cell Lung Cancer - understanding, management, diagnosis and treatment information.
What's New!
Latest News
Disease Knowledge Centres

EPG Survey Become a member of
the new EPG Survey Panel.
Your opinions matter, get paid for them! Join Now!